Lipocine
LPCN
LPCN
24 hedge funds and large institutions have $2.4M invested in Lipocine in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
86% less capital invested
Capital invested by funds: $16.6M → $2.4M (-$14.2M)
88% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 24
Holders
24
Holding in Top 10
–
Calls
$721K
Puts
$1K
Top Buyers
| 1 | +$20.7K | |
| 2 | +$2.35K | |
| 3 | +$1.29K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$45 |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$15 |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$76.8K | |
| 3 | -$59K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$56K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$51.1K |